Journal of Research in Biology
ISSN No: Print: 2231 –6280; Online: 2231- 6299
An International Scientific Research Journal
Original Research
Journal of Research in Biology
Estimates of sensitivity, specificity, false rates and expected proportion of population testing positive in screening tests Authors: ABSTRACT: Oyeka Ikewelugo Cyprian Anaene 1, Okeh Uchechukwu Marius 2, Igwebuike Victor Onyiaorah3, Adaora Amaoge Onyiaorah4 and Chilota Chibuife Efobi 5 This paper proposes and presents indices used as measures to evaluate or
assess results obtained from diagnostic screening tests. These indices include sensitivity, specificity, prevalence rates and false rates. We here present statistical methods for estimating these rates and for testing hypotheses concerning them. An estimate of the proportion of a population expected to test positive in a diagnostic screening test is also provided. Further interest is also to estimate the sensitivity and 2. Department of Industrial Mathematics and Applied specificity of the test and then the false rates as functions of sensitivity and specificity Statistics, Ebonyi State given knowledge or availability of an estimate of the prevalence rate of a condition in University Abakaliki, Nigeria. a population. The indices proposed ranges from -1 to 1 inclusively and therefore 3. Department of enables the researcher to determine if an association exists and if it exists between Histopathology, Nnamdi test results and condition as well as whether it is positive and direct or negative and Azikiwe University Teaching indirect which will serve as an advantage over the traditional methods. The proposed Hospital Nnewi Anambra State, indices provide estimates of the test statistic. When the proposed measures are Nigeria. applied, results indicate that it is easier to interpret and understand more than those 4. Department of obtained using the traditional approaches. In addition, the proposed measure is Opthalmology, Enugu State shown to be at least as efficient and hence as powerful as the traditional methods University Teaching Hospital Park lane Enugu State, Nigeria. when applied to sample data. Institution: 1. Department of Applied Statistics, Nnamdi Azikiwe University, Awka Nigeria.
5. Department of Haematology, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State Nigeria. Corresponding author: Okeh Uchechukwu Marius
Email Id:
Web Address: http://jresearchbiology.com/ documents/RA0391.pdf
Keywords: Traditional odds ratio, prevalence, sensitivity, specificity, false rates.
Article Citation: Oyeka Ikewelugo Cyprian Anaene, Okeh Uchechukwu Marius, Igwebuike Victor Onyiaorah, Adaora Amaoge Onyiaorah and Chilota Chibuife Efobi Estimates of Sensitivity, Specificity, False Rates and Expected Proportion of Population Testing Positive in Screening Tests Journal of Research in Biology (2014) 4(8): 1498-1504 Date: Received: 06 Nov 2013
Accepted: 15 Jan 2014
Published: 15 Nov 2014
This article is governed by the Creative Commons Attribution License (http://creativecommons.org/ licenses/by/4.0), which gives permission for unrestricted use, non-commercial, distribution and reproduction in all medium, provided the original work is properly cited. Journal of Research in Biology An International Scientific Research Journal
1498-1504 | JRB | 2014 | Vol 4 | No 8
www.jresearchbiology.com
Anaene et al., 2014 previous results from a gold standard test to actually
INTRODUCTION In diagnostic screening tests indices used as
have a certain condition in nature from a population and
measures to evaluate or assess results obtained include,
also takes a second random sample of n.2 subjects from
sensitivity and specificity of the test and if the prevalence
the same population Keeping in mind that known or
rate of a condition of interest in a population is known or
believed not to actually have the same condition in
can be estimated from a previous study, also the false
nature, thus giving a total random sample of size
positive and false negative rates of the test as well as the
n=n..=n.1+n.2 subjects to be studied. It is always treated
proportion of the population expected to test positive to
to confirm through a diagnostic screening test for
the condition (Fleiss, 1973; Pepe, 2003). Hence research
whether or not each sampled subjects have or does not
interest is often in statistical methods for estimating
have the condition of interest. Further interest is also to
sensitivity, specificity, false rates and the proportion of a
estimate the sensitivity and specificity of the test and
population expected to test positive to a condition in
then the false rates as functions of sensitivity and
these screening tests. The sensitivity of a test is the
specificity given knowledge or availability of an estimate
proportion of subjects testing positive among the subjects
of the prevalence rate of a condition in a population.
known or believed to actually have a condition in nature,
Now suppose B and B are respectively the
while the specificity of a test is the proportion of subjects
events that a randomly selected subject from a
who actually test negative to a condition among the
population has and does not have a condition in nature.
subjects known or believed not to actually have the
Also let A and A be respectively the events that the
condition in nature. False positive rate of a test is the
randomly selected subject tests positive, and negative to
proportion of subjects who are known or believed not to
the condition in the test. We here assume that the
actually have a condition in nature among the subjects
prevalence rate P(B) of the condition in the population is
testing positive, while false negative rate is the
either known or can be reliably estimated from previous
proportion of subjects who are known or believed to
studies. The results of such a screening test may be
actually have a condition in nature among the subjects
presented in the form of a four fold Table (Table 1).
who never-the-less test negative (Fleiss,1973;Greenberg
In Table 1 above, of the n=n.. sample subjects
et al., 2001;Linn, 2004).Sensitivity and Specificity of a
studied, n.1 subjects are known or believed to have the
test are independent of the population being studied and
condition in nature, that is in B and n.2 are known or
hence independent of the prevalence rate of a condition
B and believed not to have the condition in nature, that is B .
in the population. False rates of a test on the other hand
Also n1. subjects respond positive that is in A and n2.
are functions of the prevalence rate of a condition in a
subjects respond negative, thatAisand in A . Of the n.1
population and hence are dependent on the population of
subjects in B, n11 subjects actually have the condition
interest (Fleiss, 1973;Linn, 2004).
and test positive that is in AB and n21 subjects actually
We
here
present
statistical
methods
for
have the condition but test negative, that is in AB .
estimating these rates and for testing hypotheses
Of the n.2 subjects who are known or believed not to
concerning them. An estimate of the proportion of a
have the condition in nature,n12 subjects who do not have
population expected to test positive in a diagnostic
the condition test positive, that is in A B w h i l e n22 subjects who do not have the condition in nature also
screening test is also provided. Given that a researcher collects a random sample
test negative that is in A B. In an actual screening
of n.1 subjects known or believed, perhaps on the basis of
test usually only the total sample size n=n..,n.1 subjects
1499
Journal of Research in Biology (2014) 4(8): 1498-1504
Anaene et al., 2014 Table 1.Format for Presentation of Results of a Diagnostic Screening Test Screening Test Results
Condition Present
Condition Absent
(A)
(B) n11
B n12
Negative (Ᾱ)
n21
n22
n2.
Total (n.j)
n.1
n.2
n..(=n)
Positive
in B, n11 subjects in AB,n.2 subjects in B ¯ a n d n
2 2
subjects in A B are observed and actually known. The values n12 in AB and n21 in AB are not
Total (ni.) n1.
known or believed not to have the condition in nature. Notationally, we have that P(A) = P (AB) + P (AB )
known and hence also are n1. and n2., the overall number
3 Now to develop sample estimates of these indices,
of subjects who would test positive and negative
sensitivity for instance, we may let,
respectively in the screening test. Hence only the known values namely total sample size n, the number of
1, if the ith randomly selected and screened subject known or believed to actually have a condition in nature tests positive
ui1
subjects, n.1 known to have the condition in nature, n11,
0, otherwise
4
the number of subjects who test positive among these
for i
known to have the condition in nature, the number of
Let Let π1=1 P (ui1 =P 1) ui1 and and
subjects n.2 known not to have the condition in nature and n22 subjects who test negative among the subjects known not to have the condition in nature are used here to estimate the required indices and test statistics. Now
1, 2,...n.1 subjects
n1.
Wi = W 1
i
5
1
ui1
6
1
the sensitivity (Se) and specificity (Sp) of a screening test expressed in terms of conditional probabilities or
Now the expected value and variances of
specific rates of events A and B are respectively
E ui1
Se
P ( A / B ); Sp
P( A / B )
The higher Se and Sp are more sensitive and specific is the screening test, the lower these rates, the weaker are the sensitivity and specificity of the test. The false positive rate
: Var ui1
1
1
1
1
ui1
are
1
7
1
Similarly the expected value and variance of are respectively n1.
E W1
E (ui1 )
n.1
1
i 1
and the false negative rate of a
;Var W1
n1. i 1
Var (ui1 )
n.1
1
1
1
8
screening test also expressed in terms of conditional
Now π1 is the probability that a randomly
probabilities or specific rates of events A and B are
selected and screened subject known or believed to have
respectively
a condition in nature in a population tests positive; that is
F ve P( B / A)
1 P( A / B ) P( B ) P( A)
; F ve P( B / A)
1 P( A / B ) P ( B ) P( A)
the proportion of subjects testing positive among the 2
2
subjects in the population known or believed to actually
Where P(A) consists of the probability of
have a condition in nature. This is in fact a measure of
composition of the events AB and which is the
the sensitivity Se of the screening test. The sample
probability of the union of events that a randomly
estimate
selected subject tests positive and is known or believed to have a condition in nature or tests positive and is Journal of Research in Biology (2014) 4(8): 1498-1504
1
ˆ Se
of π1 is W1 n.1
f n.1
9
1500
8
Anaene et al., 2014 Where f+ is the number of subjects who test
condition given that the subject is known or believed not
positive among subjects in the population known or
to actually have the condition in nature. In other words,
believed to have the condition of interest in nature. In
π2 is the proportion of subjects testing negative among
+
other words, f is the number of 1s in the frequency
the population of subject known or believed not to have a
distribution of the n.1values of 1s and 0s in ui1,for i=1,2,
condition in nature. Thus π2 is actually a measure of the
+
…,n.1.Hence f =n11 of Table 1.
specificity Sp of the screening test. Its sample estimate is
The corresponding variance of is from equation (8)
from equation (18)
Var W1
ˆ Var Se
Var ˆ1
n.11
ˆ (1 Se ˆ ) Se 10 n.1
ˆ1 (1 ˆ1 ) n.1
ˆ2
W2 n.2
ˆ
10 Se
A researcher may sometimes wish to test a null
Where f
f n.2 -
19
is the number of subjects whose test
hypothesis that sensitivity of a screening test is at most
negative among the n.2 subjects in the sampled
some
population known or believed not to have a condition in
value π10 = Se0 . That is the null hypothesis, 11
11other words f - is the total number of 1s in the nature. In
This null hypothesis may be tested using the test statistic
frequency distribution of the n.2 values of 0s and 1s in
H 0 : Se
Seo
W1
2
10
n.1 Seo
versus H1 : Se
2
Seo(0
ˆ n.1 Se
Seo
ˆ (1 Se
ˆ ) Se
Var W1
Seo
1)
2
ˆ1
ˆ10
ˆ1 (1
ˆ1 )
n.1
ui2,for i=1,2,…n.2.Thus f - = n22 in Table 1. The variance
2
12
Which under Ho has approximately the chi-square distribution with one (1) degree of freedom for
12
of equation ˆ 2 Var
ˆ Sp
Var (W2 ) n.22
ˆ Var Sp
ˆ2
(18) ˆ (1 Sp ˆ ) Sp n.2
ˆ 2 (1 ˆ 2 ) n.2
20
sufficiently large n.1.the null hypothesis Ho is rejected at
A researcher may also wish to test a null hypothesis that
the level of significance if
specificity Sp of a diagnostic screening test is at least
2
2 1
13
;1
some value That is the null hypothesis Ho : Sp
Similarly to develop a sample estimate of the specificity
2
ui 2
0, otherwise for i
14
1, 2,...n.2 subjects
2
15
1
And W2
n.2
16
ui 2
2
;Var ui 2
2
1
17
2
And n.2
2
;Var W2
n.2
2
(1
2
)
18
Note that π2 is the probability that a randomly selected and screened subject tests negative to the 1501
21
W2
n.2 Spo
Var W2
2
ˆ n.2 Sp
Spo
ˆ (1 Sp
ˆ ) Sp
2
n.2
ˆ2
ˆ 20
ˆ 2 (1
ˆ2 )
2
22
Which under Ho has approximately the chisquare distribution with one (1) degree of freedom for at the level of significance if equation (13) is satisfied, 15 otherwise Ho is accepted. a population expected to 16test positive to a condition in a diagnostic screening test, we note that when expressed in
Now
E W2
1)
To develop sample estimate of the proportion of
i 1
E ui 2
Sp
sufficiently large n.2. The null hypothesis Ho is rejected
Define P ui 2
13
Spo, (0
This null hypothesis is tested using test statistic
Sp of a screening test, we may let 1, if the ith randomly selected and screened subject in the population is known or believed not to actually have a condition in nature tests negative
Spo versus H1 : Sp
20
terms of conditional probability using Bayes rule 17 equation (3) becomes P( A) P( A / B).P( B) P( A / B ).P( B ) P( A / B).P( B)
1 P( A / B ) 1 P( B)
23
18 Or when expressed in terms of sensitivity Se and specificity Sp of the screening test and prevalence rate P(B) of a condition in a population becomes Journal of Research in Biology (2014) 4(8): 1498-1504
22
Anaene et al., 2014 24
The null hypothesis Ho is expected at the α level of
The sampled estimate of P(A) is using equation ( 9) and
significance if equation (13) is satisfied; otherwise Ho is
equation (19) in equation (24)
accepted.
P( A) SeP( B) (1 Sp).P( B) 1 P( A / B) 1 P( A / B) P( A / B) .P( B) 1 Sp 1 Se Sp .P( B)
Pˆ ( A)
P( A)
ˆ ( B) SeP
ˆ ).P( B ) (1 Sp
ˆ 1 Sp
ˆ 1 Se
ˆ .P( B) Sp
25
The corresponding sample variance is ˆ )( P( B)) Var ( P( A)) Var (Se
2
ˆ ) P(( B)) Var (Sp
of false rates in a diagnostic screening test if the
ˆ ˆ ) 2P( B).P( B).Cov SeSp
2
The researcher may also wish to obtain sample estimates
26
It is easily shown that
prevalence rate P(B) of a condition in a population is known or can be determined.
ˆ ; Sp ˆ ) Cov ( Se
Cov
W1 W2 ; n.1 n.2
Now from equations (2) and (25), the sample estimate of
0
false positive rate in terms of sample estimates of
To prove this it is sufficient to show that
sensitivity and specificity and the known or estimated
Cov ui1 ; ui 2
prevalence rate is
0
Now Cov ui1 ; ui 2
E ui1 .ui 2
E (ui1 ).E (ui 2 )
E ui1 .ui1
1. 2 .
Now ui1 .ui1can assume only the values 1 and 0 . It assumes the value 1 if ui1 and ui2both assume the value 1 with probability it assumes the value 0 if assumes the values 1 and ui2 assumes the value 0 or ui1 assumes
Fˆ
(1 ve
ˆ ).P( B ) Sp P( A)
1
ˆ Sp
1
1
ˆ Se
ˆ Sp
1
P( B) ˆ .P( B) Sp
31
Similarly the sample estimate of false negative rate is from equations (2) and (25) ˆ F
ˆ ).P( B) Se P ( A)
(1 ve
ˆ Sp
1
ˆ P( B) Se
1
ˆ Se
32
ˆ .P( B) Sp
the value 0 and ui2 assumes the value 1 with probability
Where Ŝe and Ŝp are given in equation (30).
π1(1-π2) - π2(1-π1) Hence
Finally with further interest the researcher may use some
Cov ui1 ; ui 2 ˆ ) Var ( Sp ˆ ) Var ( P( A)) Var ( Se
1
2
1
2
ˆ (1 Se ˆ ) Sp ˆ (1 Sp ˆ ) Se n.1 n.2
0 so that ˆ1 (1 ˆ1 ) n.1
elementary calculus or apply Fiellers convenience
ˆ 2 (1 ˆ 2 ) n.2
27
Theory to obtain approximate estimates of the variances of Fˆ ve and Fˆ ve and also test any desired hypotheses.
The researcher may also wish to test the null hypothesis that the proportion P(A) of
subjects in a
ILLUSTRATIVE EXAMPLE
population expected to test positive to a condition in a
It a clinician is collecting a random sample of 98
diagnostic screening test is at most some value Po(A).
subjects from a certain population; twelve of whom are
That is the null hypothesis
doubted for having prostrate cancer and 86 of whom are
Ho : P( A)
Po( A) versus H1 : P( A)
Po( A), (0
Po( A) 1)
28
This null hypothesis is tested using the test statistic P ( A)
2
Var
Po( A)
assumed not to28have the disease. The clinician’s interest is to confirm through a diagnosis screening test whether or not each of the sampled subjects are actually prostrate
2
29
P ( A)
29
cancer positive or negative. The results of the screening test are presented in Table 2.
Which under Ho has approximately the chi-square
Now from Table 2 we have that the sample
distribution with one (1) degree of freedom where P(A)
estimate of the sensitivity and specificity of the test are
and Var (P(A)) are given by equations (25) and (26)
respectively
respectively and from Table 1 ˆ Se
ˆ1
f1 n.1
n11 ˆ ; Sp n.1
ˆ Se
ˆ2
f2 n.2
n22 n.2
Journal of Research in Biology (2014) 4(8): 1498-1504
30
f n.1
n
f
n
and ˆ Sp
f n.2
98 4
98 12
n.1 n
f n.2
8.167
0.041
0.335
30 n
98 84 86
98
1.140
0.857
0.977.
1502
31
Anaene et al., 2014 These results show that the screening test is low
Table 2: Result of Prostrate Cancer Screening Test
in sensitivity but has high specificity.
Clinical diagnosis
Present (B)
Now from equations (13) and (14) the sample estimates
Prostrate Cancer
n11=f + +=4
Absent B n12=f+ - =4
n1.= 6
of are respectively
Positive (A)
n21=f - +=4
n22=f - - =4
n2.=92
Negative (Ā)
n.1=12
n.2=86
n..=n=98
12 0.335
ˆ
86 0.977
0.898
98
and 12 1 0.335
ˆ
86 1 0.977
0.102
98
Hence from equations (15) and (17) we have that
ˆ
ˆ
ˆ
0.898 0.102
0.796
expected to be correctly informed. This probably makes more difficulty in understanding than the simple information conveyed by the simple difference in rates, ˆ
ˆ
ˆ
0.796,
namely, the proportion of subjects
With estimated variance obtained from equations (16)
testing positive among subjects who have prostrate
and (18) as
cancer or testing negative among subjects who do not
Var ( ˆ )
Var ( ˆ
ˆ )
1 (0.796) 98
2
0.004
have prostrate cancer is 79.6 percent higher than the proportion of subjects testing positive among subjects
Hence the test statistic of no association between
who do not have prostrate cancer or testing negative
screening test results and state of nature or condition
among subjects who have the disease.
(Prostrate Cancer) of equation (19) are obtained from equation (20) as
0.796
Se(O)
O
1 n11
1 n12
1 n21
1 n22
21.00
1 4
1 2
1 8
1 84
(21.00)(0.942) 19.782
2
0.634 158.500( P value 0.0000) 0.004 0.004 Which with one (1) degree of freedom is highly
This measure of the error of ‘O’ namely 19.782
statistically significant indicating a strong degree of
Se
association between screening test results and state of
sample data. The chi-square test statistic for the
nature or condition (presence of Prostrate cancer in
significance of ‘O’ is
2
the population). Also since ˆ
ˆ
ˆ
0.796
is positive, the association is positive and direct.
is clearly much larger than the error of only ˆ
X2=
0.004
0.063
of the estimated value of for our
n(n11n22–n12 n21)2 98(94)(84)-(2)(8)2 =
n1.n2.n1.n2
=17.616 (p-value=0.0000)
(6)(92)(12)(86)
It is commendable to compare the present results with
Which is also statistically significant again leading to a
what would have been obtained if we have used the
rejection of the null hypothesis of no association.
traditional odds ratio to analyze the data of Table 2. In
However, the proposed method and the traditional odds
spite of odds ratio’s short comings as already pointed out
ratio approach explained here (both) lead to a rejection of
above, when used in the analysis of screening test results.
the null hypothesis, the relative sizes of the calculated
The sample estimate of the traditional odds ratio for the
chi-square values suggest that the traditional odds ratio
data of Table 2 is
method is less efficient and likely to lead to an
O
n11 n22 n12 n21
(4)(84) (2)(8)
21.00
This means, for every subject who has prostrate cancer
acceptance of a false null hypothesis (Type II Error) more frequently and hence is likely to be less powerful than the proposed method.
among tested subjects and erroneously informed that they are free of the disease (21 subjects) among those tested and found to have prostrate cancer would be 1503
Journal of Research in Biology (2014) 4(8): 1498-1504
Anaene et al., 2014 CONCLUSION In this paper, we proposed, developed and presented a statistical method for measuring the strength of association between test results and state of nature or condition in a population expressed to a diagnostic screening test. The proposed measure is based on only the sensitivity and specificity of the screening test which are independent of the population of interest and estimated using only observed sample values. The proposed measure which ranges from -1 to 1 can be used to establish whether an association is strong and direct, strong and indirect or zero estimates of the standard error. Test statistics for the significance of the proposed measure are provided. The proposed measure of association is shown to be easier to interpret and explain than the traditional odds ratio, and the sample data used suggest that the measure is at least as efficient and powerful as the traditional odds ratio. REFERENCE Baron
JA
and
Sorensen
HT.
2010.
Clinical
epidemiology, in Teaching Epidemiology: A guide for teachers in epidemiology, public health and clinical medicine. eds. Olsen J; Saracci R and Trichopoulos D; Oxford: Oxford University Press, 237-249. Fleiss JL. 1973. Statistical Method for Rates and Proportions. John Wiley, New York. Greenberg RS, Daniels SR, Flanders WD, Eley JW and Boring JR. 2001. Medical Epidemiology, London: Lange-McGraw- Hill.
Submit your articles online at www.jresearchbiology.com Advantages
Pepe MS. 2003. The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford statistical series 28, Oxford: University Press, U.K. Shai Linn. 2004. A new Conceptual Approach to
Easy online submission Complete Peer review Affordable Charges Quick processing Extensive indexing You retain your copyright
teaching the interpretation of clinical tests. Journal of
submit@jresearchbiology.com
statistics education 12(3). www.amstat.org/publications/
www.jresearchbiology.com/Submit.php
jse/v12n3/linn.html. Journal of Research in Biology (2014) 4(8): 1498-1504
1504